H2CasMab-2 selectively recognized HER2 expressed on breast carcinoma cells, while showing negligible reactivity with HER2 on normal epithelial cells, derived from mammary gland, colon, lung bronchus, renal proximal tubule, and colon [42]. Here, ERBB2 is linked to breast carcinoma.